This paper presents some initial findings that pertain to the identification of health disparities from this unique database, including cancer disparities according to individual-level socioeconomic status and demographic characteristics for all cancers combined and for cancers of the lung, breast, prostate, cervix, and melanoma.
Background. The application of health-related quality of life (HRQOL) as a pediatric population health measure may facilitate risk assessment and resource allocation, the tracking of community health, the identification of health disparities, and the determination of health outcomes from interventions and policy decisions.
Identification of persistent disparities between the groups would help guide policy efforts and increase funding to increase colorectal cancer screening rates in rural populations.
Given that the population of PR has experienced an acculturation process different from that of USH, the comparison of OPC incidence and mortality between these groups and the NHW and NHB populations is essential for further understanding differences and similarities of disease occurrence between these groups, that permit the identification of health disparities.
The application of health-related quality of life (HRQOL) as a pediatric population health measure may facilitate risk assessment and resource allocation, the identification of health disparities, and the determination of health outcomes from interventions and policy decisions for children and adolescents with ADHD at the local community, state, and national health level.
The goal of this research is to create a theoretical framework for the identification of cancer risk factor disparities and address the recognition of geographic patterns in these factors.
It provides a comprehensive, updated picture of the situation of children and women, including the identification of vulnerable groups and disparities, to inform policies and interventions.
Better identification of reasons for treatment disparities in this group may enable cancer care providers to increase treatment uptake and in turn improve overall survival.
Achieving this goal will require the identification of the root cause of socioeconomic disparities in CKD, as well as targeted public and clinical interventions to mitigate these disparities.
